 LA JOLLA, Calif.--BUSINESS WIRE--DermTech, Inc. NASDAQ: DMTK DermTech, a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today it has entered into an agreement, effective February 1, 2021, with Blue Shield of California for reimbursement coverage for all of its products. Blue Shield of California has approximately 3.7 million covered lives in California through its Commercial PPOEPO, Medicare Advantage PPO, Commercial HMO and Medicare Advanta 